Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.
In 2015, research led the World Health Organization to recommend treating HIV regardless of CD4 count.
The increasing mastery over the virus is one of humanity’s crowning achievements.
This finding comes from an analysis of the global START study, which proved in 2015 that starting HIV treatment early is best.
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
Although more research on antiretroviral linked bone loss is needed, the overall health benefits of early treatment outweigh such a risk.
The major trial compared those starting HIV treatment immediately and those waiting till their CD4 counts dropped below 200.
Starting HIV treatment soon after diagnosis leads to modest improvements in quality of life compared with delaying treatment.
Here’s a timeline of the highlights.
Those who start antiretrovirals with more than 500 CD4 cells have a lower risk of developing infection-related cancers.
Those who begin HIV treatment soon after diagnosis experience more bone loss than those who defer taking antiretrovirals until HIV disease has...
HIV raises the risk of heart disease. What can you do to lower that risk?
An overview of studies presented at the International AIDS Society Conference in Vancouver, British Columbia.
A new analysis of the major trial that provided gold-standard scientific proof supporting early treatment of HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.